Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NeuroClues

Request full access

The brain stethoscope providing CNS biomarkers in a Blink

Ottignies-Louvain-la-Neuve, BelgiumFounded 2020Biotech & Life Sciences

About NeuroClues

neuroClues (powered by P3Lab) is a French-Belgian MedTech company founded in 2020 by Antoine Pouppez, Pierre Daye and Pierre Pouget. It develops a compact, CE-marked Class IIa medical device that records high-speed infrared eye movements during simple visual tasks and extracts objective neurological biomarkers to help clinicians assess anomalies earlier than traditional observation or costly imaging—positioned as a “stethoscope for the brain” for Parkinson’s, Alzheimer’s and related disorders. After CE certification in January 2025 and 30+ deployments across Europe, neuroClues raised a €10 million Series A in April 2026 led by Teampact Ventures, White Fund and the EIC Fund, with InvestBW, Leansquare, Wallonie Entreprendre and support from Olivier Legrain (IBA); with additional non-dilutive capital, total funding reaches €25 million. Sources: EU-Startups 7 Apr 2026.

Source: Dealroom company data

At a glance

Status
Operational
Employees
35
Open positions
None listed
Dealroom signal
80.9/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Biomarkers
Technology
Artificial Intelligence, Hardware, Big Data, Deep Tech, Computer Vision, Connected Device
Business model
Manufacturing, SaaS
Client focus
B2B

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBT✓Debt Apr 2026 $0 — Undisclosed ↗
SERIES A✓Equity / VC Apr 2026 $11M $44M Olivier Legrain · Wallonie Entreprendre · EIC Fund · Teampact Ventures ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

NeuroClues website traffic

Latest recorded traffic for NeuroClues is 3.1K monthly website visits, up 158.3% over the last three months. NeuroClues's team grew 12.9% over the past year.

Latest monthly visits3.1K 3-month web change+158.3% 1-year team growth+12.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

NeuroClues in the Ottignies-Louvain-la-Neuve ecosystem

Live from Dealroom

The NeuroClues office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

  • European Innovation Council
  • White fund
  • Olivier Legrain
  • Wallonie Entreprendre
  • Fiona du Monceau - de Hemptinne
  • WE Venture

Series A7 investors entered at this stage

  • Graph Ventures
  • Invest.BW
  • Jean-Charles Samuelian
  • Wing
  • EIC Fund
  • Teampact Ventures
  • LeanSquare

Other known investors1 additional known investor

  • EIT Health
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See NeuroClues’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.